Possible explanations included: advanced stage at diagnosis, increased paracrine sex hormones in the surrounding adipose tissue 49, attenuated post-chemotherapy amenorrhea effects in obese women, and lower levels of circulating estradiol in premenopausal women who were more sensitive to high-ER tumor status. The gene discussed is ESR1; the disease is amenorrhea.